
Chai Discovery: AI Designing Proteins Like Software
Chai Discovery's co-founders discuss how their AI platform is revolutionizing protein design and drug discovery, making biology feel more like software development.
Drug discovery coverage across healthcare.

Chai Discovery's co-founders discuss how their AI platform is revolutionizing protein design and drug discovery, making biology feel more like software development.

Chai Discovery's co-founders discuss their approach to AI-driven drug design, emphasizing simplicity, scaling laws, and the transformation of biology into an engineering discipline.

Jennifer Doudna discusses Scribe Therapeutics' non-permanent gene editing tech, its potential for common diseases, and the role of AI in science.

Pharmaceutical companies are increasingly turning to AI to accelerate drug discovery, reduce costs, and bring life-saving medicines to market faster.

Boston Children's Hospital's Dr. Joan LaRovere discusses AI's transformative role in healthcare, emphasizing data diversity and personalized medicine.